A modified platform for bi-specific antibody and characterizations of an anti-EGFR/c-Met bi-specific antibody
碩士 === 國立清華大學 === 生物科技研究所 === 100 === 因申請專利緣故,資料延後公開
Main Author: | 黃俊惟 |
---|---|
Other Authors: | 徐祖安 |
Format: | Others |
Language: | zh-TW |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/32903629941123707898 |
Similar Items
-
Characterization of in vivo resistance to osimertinib and JNJ-61186372, an EGFR/Met bi-specific antibody, reveals unique and consensus mechanisms of resistance
by: Moores, Sheri L., et al.
Published: (2018) -
Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics
by: Karie Runcie, et al.
Published: (2018-09-01) -
Recent Advances on Immune Targeted Therapy of Colorectal Cancer Using bi-Specific Antibodies and Therapeutic Vaccines
by: Ali Azadi, et al.
Published: (2021-07-01) -
Generation of dual specific bivalent BiTEs (dbBIspecific T-cell engaging antibodies) for cellular immunotherapy
by: Maciej Kujawski, et al.
Published: (2019-09-01) -
Generation and characterization of anti-AA amyloid-specific monoclonal antibodies
by: Jonathan S Wall, et al.
Published: (2011-08-01)